MedPath

Efficacy, tolerability and safety of 0.2% Brimonidine-Tartrate for the treatment of acute non-arteritic anterior ischaemic optic neuropathy

Not Applicable
Completed
Conditions
Eye Diseases: Non-arteritic anterior ischemic optic neuropathy
Eye Diseases
Other disorders of optic [2nd] nerve and visual pathways
Registration Number
ISRCTN72549635
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with acute non-arteritic anterior ischemic optic neuropathy

Exclusion Criteria

Does not match inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath